Eric Snoeck

1.4k total citations
44 papers, 1.1k citations indexed

About

Eric Snoeck is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Eric Snoeck has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pediatrics, Perinatology and Child Health, 9 papers in Psychiatry and Mental health and 8 papers in Physiology. Recurrent topics in Eric Snoeck's work include Hepatitis C virus research (7 papers), HIV/AIDS drug development and treatment (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Eric Snoeck is often cited by papers focused on Hepatitis C virus research (7 papers), HIV/AIDS drug development and treatment (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Eric Snoeck collaborates with scholars based in Belgium, Switzerland and United States. Eric Snoeck's co-authors include Philippe Jacqmin, Geert Mannens, Karin Jorga, J Heykants, A. Van Peer, W. Meuldermans, Janet R. Wade, Franck Le Duff, Walter Wouters and R. De Coster and has published in prestigious journals such as Blood, Journal of Hepatology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Eric Snoeck

43 papers receiving 1.1k citations

Peers

Countries citing papers authored by Eric Snoeck

Since Specialization

Citations

This map shows the geographic impact of Eric Snoeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Snoeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Snoeck more than expected).

Fields of papers citing papers by Eric Snoeck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Snoeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Snoeck. The network helps show where Eric Snoeck may publish in the future.

Co-authorship network of co-authors of Eric Snoeck

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Snoeck. A scholar is included among the top collaborators of Eric Snoeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Snoeck. Eric Snoeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exposure‐Efficacy Analysis and Dopamine D2 Receptor Occupancy in Adults with Schizophrenia after Treatment with the Monthly Intramuscular Injectable Risperidone ISM 2024 ·The Journal of Clinical Pharmacology ·Andreas Lindauer, Eric Snoeck, Christian Laveille, (unknown), (unknown), (unknown), Javier Martínez, (unknown), I. Gutierro	2
2	Development of a population pharmacokinetic model for the novel long‐acting injectable antipsychotic risperidone ISM® 2024 ·British Journal of Clinical Pharmacology ·Christian Laveille, Eric Snoeck, (unknown), Javier Martínez, (unknown), (unknown), I. Gutierro	5
3	Pharmacokinetic/pharmacodynamic modeling and simulation of dopamine D2-receptor occupancy-time profiles comparing Risperidone ISM versus daily oral risperidone 2023 ·Neuroscience Applied ·Eric Snoeck, (unknown), Christian Laveille, (unknown), (unknown), I. Gutierro	1
4	Pharmacokinetic/pharmacodynamic modeling and simulation of dopamine D2-receptor occupancy-time profiles comparing monthly risperidone ISM versus monthly paliperidone palmitate 2023 ·Neuroscience Applied ·Eric Snoeck, (unknown), Christian Laveille, (unknown), (unknown), I. Gutierro	1
5	Knowledge and Attitude of the Flemish Primary Care Physician Toward Organ Donation and Transplantation 2014 ·Transplantation Proceedings ·(unknown), Eric Snoeck, Jan De Maeseneer, (unknown), Wim Peersman, Roberto Troisi, Xavier Rogiers	13
6	The Dose-Response Relationship of Peginterferon Alfa-2a and Ribavirin in the Treatment of Patients Coinfected with HIV-HCV 2012 ·HIV Clinical Trials ·Milos Opravil, M. Rodríguez‐Torres, Jürgen K. Rockstroh, Eric Snoeck, Raymond T. Chung, Andreas Tietz, Francesca J. Torriani	2
7	Long-Term Results of a Prospective Study on Laparoscopic Adjustable Gastric Banding for Morbid Obesity 2010 ·Obesity Surgery ·Yves Van Nieuwenhove, Wim Ceelen, Annelies Stockman, (unknown), Eric Snoeck, Katrien Van Renterghem, Dirk Van de Putte, Piet Pattyn	50
8	Pharmacokinetics and Pharmacodynamics of the Non-Nucleoside Reverse-Transcriptase Inhibitor Etravirine in Treatment-Experienced HIV-1-Infected Patients 2010 ·Clinical Pharmacology & Therapeutics ·Thomas N. Kakuda, Janet R. Wade, Eric Snoeck, Peter Vis, Monika Schöller‐Gyüre, Monika Peeters, Chris Corbett, Steven Nijs, Johan Vingerhoets, Lorant Leopold, Goedele De Smedt, Brian Woodfall, Richard M. W. Hoetelmans	37
9	Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa‐2a (40KD) plus ribavirin 2006 ·British Journal of Clinical Pharmacology ·Eric Snoeck, Janet R. Wade, Franck Le Duff, Matthew W. Lamb, Karin Jorga	69
10	Modelling Response Time Profiles in the Absence of Drug Concentrations: Definition and Performance Evaluation of the K–PD Model 2006 ·Journal of Pharmacokinetics and Pharmacodynamics ·Philippe Jacqmin, Eric Snoeck, E.A. van Schaick, Ronald Gieschke, P. Krishna Pillai, Jean‐Louis Steimer, Pascal Girard	141
11	Dose–response population analysis of levetiracetam add-on treatment in refractory epileptic patients with partial onset seizures 2006 ·Epilepsy Research ·Eric Snoeck, Armel Stockis	15
12	Modelling and simulation in clinical drug development 2001 ·Drug Discovery Today ·(unknown), Eric Snoeck, (unknown)	16
13	A pharmacokinetic and pharmacodynamic interaction study between nebivolol and the H₂‐receptor antagonists cimetidine and ranitidine 1997 ·British Journal of Clinical Pharmacology ·Farhad Kamali, Angela Howes, S. H. L. Thomas, Gary A. Ford, Eric Snoeck	29
14	Pharmacokinetics of β‐adrenoceptor blockers in obese and normal volunteers 1997 ·British Journal of Clinical Pharmacology ·(unknown), Jean‐Marie Poirier, Pierre‐Alain Carrupt, (unknown), (unknown), Jean‐Claude Levron, Eric Snoeck	64
15	Pharmacokinetic study and cardiovascular monitoring of nebivolol in normal and obese subjects 1997 ·European Journal of Clinical Pharmacology ·G Cheymol, Robert Woestenborghs, Eric Snoeck, (unknown), (unknown), (unknown), J. C. Levron, J.‐M. POIRIER	45
16	Population analysis of the non linear red blood cell partitioning and the concentration‐effect relationship of draflazine following various infusion rates 1997 ·British Journal of Clinical Pharmacology ·Eric Snoeck, (unknown), Philippe Jacqmin, A. Van Peer, Meindert Danhof, (unknown), R. Woestenborghs, Herman Van Belle, L. Van Bortel, (unknown), Alain Dupont, J. Heykants	5
17	Population analysis of the non-linear red blood cell partitioning of draflazine following various infusion durations 1997 ·European Journal of Clinical Pharmacology ·Eric Snoeck, (unknown), Philippe Jacqmin, R. Lins, A. Van Peer, Meindert Danhof, Robert Woestenborghs, (unknown), Alain Dupont, J. Heykants	2
18	Haemodynamic effects and pharmacokinetics of oral d -and l -nebivolol in hypertensive patients 1996 ·European Journal of Clinical Pharmacology ·Anders Himmelmänn, Thomas Hedner, Eric Snoeck, Bo Lundgren, Jan Hedner	29
19	Pharmacokinetic-pharmacodynamic relationships in Phase I/Phase II of drug development 1993 ·European Journal of Drug Metabolism and Pharmacokinetics ·A. Van Peer, Eric Snoeck, Minxue Huang, J Heykants	14
20	R 75251, a new inhibitor of steroid biosynthesis 1990 ·The Prostate ·J. Bruynseels, R. De Coster, P. Van Rooy, Walter Wouters, M C Coene, Eric Snoeck, Alfons H. M. Raeymaekers, Eddy Freyne, Gérard Sanz, (unknown), (unknown), G. Willemsens, Patricia A. Janssen	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact